New Era Energy units secure $116 million standby letter of credit from Macquarie Bank for Luminant PPA obligations
Bitget2026/10/08 10:05New Era Energy & Digital subsidiaries PowerCo, TCDC signed a letter of credit reimbursement agreement with Macquarie Bank on Oct. 7, 2026. Macquarie issued a USD 116 million standby letter of credit backing PowerCo’s obligations under its PPA with Luminant. PowerCo must reimburse any draw, paying 12% annual interest; TCDC provided an unconditional guarantee with joint and several liability. Facility is secured by cash collateral set at 102% of the undrawn amount, initially about USD 118.3 million, including USD 60 million from term loans. Macquarie Equipment Capital received warrants for 413,055 shares at an exercise price of about USD 7.26; fees include 1% upfront. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. New Era Energy & Digital Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-107704), on October 08, 2026, and is solely responsible for the information contained therein.
- New Era Energy & Digital subsidiaries PowerCo, TCDC signed a letter of credit reimbursement agreement with Macquarie Bank on Oct. 7, 2026.
- Macquarie issued a USD 116 million standby letter of credit backing PowerCo’s obligations under its PPA with Luminant.
- PowerCo must reimburse any draw, paying 12% annual interest; TCDC provided an unconditional guarantee with joint and several liability.
- Facility is secured by cash collateral set at 102% of the undrawn amount, initially about USD 118.3 million, including USD 60 million from term loans.
- Macquarie Equipment Capital received warrants for 413,055 shares at an exercise price of about USD 7.26; fees include 1% upfront.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
